Enavate Sciences Gp, Llc Portfolio Stock Holdings
According to the SEC 13F filed on August 14, 2026, Enavate Sciences Gp, Llc disclosed 7 stock positions valued at approximately $345.38M as of quarter-end June 30, 2026. The largest holdings include SIONNA THERAPEUTICS INC, ZENAS BIOPHARMA INC, and IMMUNOME INC.
- Report Period
- June 30, 2026
- No. of Stocks
- 7
- Portfolio Value
- $345.38M
Holdings by Sector
Enavate Sciences Gp, Llc Portfolio Holdings in Q2 2026
| Company | Symbol | Sector | Portfolio % | Shares | Change (Shares) | Change % | Value |
|---|---|---|---|---|---|---|---|
| SIONNA THERAPEUTICS INC | SION | Healthcare | 31.56% | 2,478,030 | - | - | $109,008,540 |
| ZENAS BIOPHARMA INC | ZBIO | Healthcare | 28.80% | 3,919,159 | - | - | $99,468,255 |
| IMMUNOME INC | IMNM | Healthcare | 22.17% | 3,613,799 | - | - | $76,576,401 |
| BRIDGEBIO ONCOLOGY THERAPEUT | BBOT | Healthcare | 5.80% | 2,626,946 | - | - | $20,017,329 |
| COMPASS THERAPEUTICS INC | CMPX | Healthcare | 4.94% | 7,788,150 | - | - | $17,056,049 |
| UPSTREAM BIO INC | UPB | Healthcare | 4.93% | 2,459,703 | - | - | $17,021,145 |
| CAMP4 THERAPEUTICS CORP | CAMP | Healthcare | 1.80% | 1,425,541 | -765,379 | -34.93% | $6,229,614 |
Showing 7 of 7 holdings in the latest reporting period.